Overexpression of complement C5a indicates poor survival and therapeutic response in metastatic renal cell carcinoma.

Yang, Changjun; Yang, Faying; Chen, Xiang; Li, Yunpeng; Hu, Xiaoyi; Guo, Jianming; Yao, Jiaxi

Yang, Changjun; Yang, Faying; Chen, Xiang; Li, Yunpeng; Hu, Xiaoyi; Guo, Jianming; Yao, Jiaxi.

Afiliação

Yang C; Department of Urology, Hexi University Affiliated Zhangye People's Hospital, Gansu, China.
Yang F; Institute of Urology, Hexi University, Zhangye Gansu, China.
Chen X; Department of Urology, Hexi University Affiliated Zhangye People's Hospital, Gansu, China.
Li Y; Institute of Urology, Hexi University, Zhangye Gansu, China.
Hu X; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
Guo J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yao J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.

Int J Biol Markers ; 38(2): 124-132, 2023 Jun.

Article em En | MEDLINE | ID: mdl-36883235

Assuntos

Carcinoma de Células Renais; Neoplasias Renais; Humanos; Carcinoma de Células Renais/patologia; Receptor de Morte Celular Programada 1; Neoplasias Renais/genética; Neoplasias Renais/patologia; Antígeno B7-H1/metabolismo; Complemento C5a/genética; Complemento C5a/farmacologia; Complemento C5a/uso terapêutico; Transição Epitelial-Mesenquimal/genética

Palavras-chave

Complement C5a; epithelial-mesenchymal transition; immunosuppression; metastatic renal cell carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Limite: Humans Idioma: En Revista: Int J Biol Markers Assunto da revista: BIOQUIMICA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google